Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,961.00
Bid: 1,961.00
Ask: 1,964.00
Change: 3.00 (0.15%)
Spread: 3.00 (0.153%)
Open: 1,977.00
High: 1,977.00
Low: 1,958.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: De La Rue climbs on profit, broker comment

Wed, 28th May 2014 14:00

Banknote printer De La Rue rose after it posted a 43% jump in full-year underlying operating profit and said it has entered the new financial year with a good order book. Helping it higher was Investec, which upped its target price from 890p to 915p and left its 'buy' recommendation unaltered.Also on the rise was Serco, which has been selected to manage the new 15-year franchise for the Caledonian Sleeper service between London and several Scottish cities. From April 1st 2015, the company will take over from FirstGroup which currently operates the service through its ScotRail franchise.Despite the news, FirstGroup remained in positive territory, up around 0.3%. Infrastructure specialist Balfour Beatty was higher on the news it has won a further framework contract with Heathrow Airport worth between £180m over three years. The group, which could see the framework increased by £70m over a further two years from 2016, will work with Heathrow to maintain and upgrade Terminals 1, 2 and 4.Hikma Pharmaceuticals was also in positive territory, having agreed to acquire certain key assets of the Bedford Laboratories generic injectables business from US-based Ben Venue Laboratories for up to $300m. The purchase will be made for an initial $225m upfront cash payment as well as up to a further $75m in contingent cash payments during the following five-year period.Meanwhile, Cable & Wireless Communications fell sharply, which may be linked to reports it is planning to up its investment in its Caribbean and Central American networks. According to various reports, the group is planning to invest more than $1bn in the next three years on fixed and mobile networks. FTSE 250 - RisersDe La Rue (DLAR) 883.00p +9.01%Ocado Group (OCDO) 368.70p +6.99%Kazakhmys (KAZ) 276.00p +4.15%Lancashire Holdings Limited (LRE) 639.50p +3.81%Laird (LRD) 296.00p +3.75%Vedanta Resources (VED) 1,101.00p +3.57%RPS Group (RPS) 298.40p +3.54%SIG (SHI) 192.50p +3.49%Serco Group (SRP) 367.20p +3.44%UBM (UBM) 689.00p +3.14%FTSE 250 - FallersBwin.party Digital Entertainment (BPTY) 117.40p -3.22%Cable & Wireless Communications (CWC) 53.80p -3.06%Amec (AMEC) 1,171.00p -2.82%Rightmove (RMV) 2,279.00p -2.61%Marston's (MARS) 150.50p -2.53%Aveva Group (AVV) 2,299.00p -2.17%Inchcape (INCH) 624.50p -2.04%Barr (A.G.) (BAG) 626.50p -1.96%Fidessa Group (FDSA) 2,249.00p -1.88%Bellway (BWY) 1,378.00p -1.64%NR
More News
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
2 Dec 2020 13:11

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.

Read more
24 Nov 2020 13:33

Tuesday broker round-up

(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.

Read more
10 Nov 2020 13:17

Tuesday broker round-up

(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.

Read more
10 Nov 2020 09:44

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

Read more
5 Nov 2020 10:44

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

Read more
5 Nov 2020 09:24

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

Read more
5 Nov 2020 09:15

Hikma raises FY guidance for generics unit following positive H1 momentum

(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.

Read more
4 Nov 2020 17:06

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

Read more
4 Nov 2020 12:12

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

Read more
4 Nov 2020 10:38

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 11:03

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.